关注并星标CPHI制药在线*展会预登记火热进行中, 扫描二维码免费领票!8月8日,全球生物制药巨头吉利德宣布对其研发管线进行重大调整。在刚刚推出革命性HIV预防药物Yeztugo后,该公司开始着手清理研发管线。此次被砍掉的三个项目涵盖了癌症和代谢疾病两大热门领域,包括两款早期癌症候选药物和一项与诺和诺德合作的脂肪肝治疗项目。一、战略转型,聚焦核心优势2025年对吉利德而言是里程碑式的一年。6月,该...
Source Link关注并星标CPHI制药在线*展会预登记火热进行中, 扫描二维码免费领票!8月8日,全球生物制药巨头吉利德宣布对其研发管线进行重大调整。在刚刚推出革命性HIV预防药物Yeztugo后,该公司开始着手清理研发管线。此次被砍掉的三个项目涵盖了癌症和代谢疾病两大热门领域,包括两款早期癌症候选药物和一项与诺和诺德合作的脂肪肝治疗项目。一、战略转型,聚焦核心优势2025年对吉利德而言是里程碑式的一年。6月,该...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.